![The 340B Drug Pricing Program: Background, Ongoing Challenges and Recent Developments – USC Schaeffer The 340B Drug Pricing Program: Background, Ongoing Challenges and Recent Developments – USC Schaeffer](https://healthpolicy.usc.edu/wp-content/uploads/2021/10/Fig-6.png)
The 340B Drug Pricing Program: Background, Ongoing Challenges and Recent Developments – USC Schaeffer
![Use of State Medicaid Inflation Rebates Could Discourage Drug Price Increases | The Pew Charitable Trusts Use of State Medicaid Inflation Rebates Could Discourage Drug Price Increases | The Pew Charitable Trusts](https://www.pewtrusts.org/-/media/post-launch-images/2018/06/implementingstatemedicaidinflationrebatescoulddiscouragedrugpriceincreases_webgraphic.png)
Use of State Medicaid Inflation Rebates Could Discourage Drug Price Increases | The Pew Charitable Trusts
![Drug Rebate Proposal Fundamentally Changes Current System, Raises Critical Questions | Avalere Health Drug Rebate Proposal Fundamentally Changes Current System, Raises Critical Questions | Avalere Health](https://avalere.com/wp-content/uploads/2019/02/drug-rebate-proposal-f1.png)
Drug Rebate Proposal Fundamentally Changes Current System, Raises Critical Questions | Avalere Health
![How State Medicaid Programs are Managing Prescription Drug Costs – Payment, Supplemental Rebates and Rebate Management – 9439 | KFF How State Medicaid Programs are Managing Prescription Drug Costs – Payment, Supplemental Rebates and Rebate Management – 9439 | KFF](https://www.kff.org/wp-content/uploads/2020/04/Medicaid-pharmacy-state-survey_placeholder-feature-image-2.png)